Osborne CK - Search Results

1

Tamoxifen in the treatment of breast cancer.

Osborne CK. Osborne CK. N Engl J Med. 1998 Nov 26;339(22):1609-18. doi: 10.1056/NEJM199811263392207. N Engl J Med. 1998. PMID: 9828250 Review. No abstract available.

2

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.

Wiebe VJ, Osborne CK, McGuire WL, DeGregorio MW. Wiebe VJ, et al. Among authors: osborne ck. J Clin Oncol. 1992 Jun;10(6):990-4. doi: 10.1200/JCO.1992.10.6.990. J Clin Oncol. 1992. PMID: 1588380

3

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study.

Osborne CK, Blumenstein BA, Crawford ED, Weiss GR, Bukowski RM, Larrimer NR. Osborne CK, et al. Eur J Cancer. 1992;28(2-3):477-8. doi: 10.1016/s0959-8049(05)80080-2. Eur J Cancer. 1992. PMID: 1591066 Clinical Trial.

4

Dose intensity as a therapeutic strategy in breast cancer.

Osborne CK. Osborne CK. Breast Cancer Res Treat. 1991 Dec;20 Suppl:S11-4. doi: 10.1007/BF01908239. Breast Cancer Res Treat. 1991. PMID: 1687202

5

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

Osborne CK, Wiebe VJ, McGuire WL, Ciocca DR, DeGregorio MW. Osborne CK, et al. J Clin Oncol. 1992 Feb;10(2):304-10. doi: 10.1200/JCO.1992.10.2.304. J Clin Oncol. 1992. PMID: 1732430

6

Hematopoietic growth factors in breast cancer--overview.

Osborne CK. Osborne CK. Breast Cancer Res Treat. 1991 Dec;20 Suppl:S1-2. doi: 10.1007/BF01908237. Breast Cancer Res Treat. 1991. PMID: 1806028 No abstract available.

7

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M. Osborne CK, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493

8

Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study.

Von Hoff DD, Green SJ, Neidhart JA, Fabian C, Budd T, Boyd JF, Osborne CK. Von Hoff DD, et al. Among authors: osborne ck. Invest New Drugs. 1991 Feb;9(1):87-8. doi: 10.1007/BF00194553. Invest New Drugs. 1991. PMID: 2026487 Clinical Trial. No abstract available.

9

Tamoxifen in premenopausal patients with metastatic breast cancer: a review.

Sunderland MC, Osborne CK. Sunderland MC, et al. Among authors: osborne ck. J Clin Oncol. 1991 Jul;9(7):1283-97. doi: 10.1200/JCO.1991.9.7.1283. J Clin Oncol. 1991. PMID: 2045868 Review.

10

Regulation of breast cancer growth by insulin-like growth factors.

Osborne CK, Clemmons DR, Arteaga CL. Osborne CK, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):805-9. doi: 10.1016/0960-0760(90)90423-i. J Steroid Biochem Mol Biol. 1990. PMID: 2178363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters